Supporting Evidence (Efficacy/Functionality):
Provide all supporting literature and research studies, publications, protocols, and analytical assessment.
Please separate data into:
o Mechanism of Action/s (MOA)
: Lipase, ACAT, HMG-CoA reductase inhibition, appetite reduction, leptin increase
steroid excretion increase.
o Chemistry/Characterization data
o In vitro bioassaydata
o In vivo testing (Laboratory, Animal, and Human Clinical Studies)
o In vivo testing
: See the attached material publications.
o Clinically tested : Naringin / hesperidin
§ Provide studies done by Company on the ingredient. : See the attached. brochure
§ Total number of clinical studies completed? : 1
§ Study design? (number of subjects, duration of the study/ies, double-blinded, placebo-controlled, case controlled, etc.) : 9
§ Percent response rate? : 100%
§ Dose and delivery form used in the study/ies : 500mg/capsule
o Published or not published, and in which journal/s?
o Recommended Delivery form/s? : 500mg/capsule
o Recommended dose/s? (mg per day) : 500mg/Day
o Collaborating Organizations, professors or University Affiliations
: Seoul National Univ. Medical School& --- Prof. Park, Young Bae
o Conclusions from the studies: Good for cholesterol lowering.
Provide an IP Portfolio summary to include : See the attached.
o Provide patent information
§ How is the patent unique, compared to competition?
§ Number of patents?
§ Patent Type? (Process, Application, Combination, Composition, or other)
§ Patent Number/s, title, abstract, claims and application/issue dates
o Describe exclusivity options : global (possible)
Yong U KIM
Business Development Manager
Health Technology Transfer Center
KHIDI, provides various services on technology transfer. KHIDI will license and commercialise several technologies of KHIDI's client companies via collaboration with overseas partners.View profile
Clients in focus...